Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
Clinical trial NCT02092467 · COMPLETED
Trial details
- NCT number
- NCT02092467
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-14
- Primary completion
- 2020-07-22
- Enrollment
- 4372
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.